9001zz以诚为本(中国)有限公司
中文
英文
Home
About Us
Overview
Our People
Our Workplace
Products
Hypoglycemic drugs
Antineoplastic
Cardiovascular drugs
Others
Solutions
Chemistry
Custom Chemical Synthesis
FTE
Biology Services
In Vivo Efficacy Evaluation1
In Vitro Biological Screening
DMPK
In Vivo Pharmacokinetic Assays
In Vitro Pharmacokinetic Assays
Drug Safety Evaluation
Recruitment
Recruitment
Contact Us
中文版
Product center
Hypoglycemic drugs
Antineoplastic
Cardiovascular drugs
Others
Contact Us
Tel:
86-15000803246
Add:3rd Floor, Building 4, 3918 Daye Road, Fengxian District, Shanghai, China, 201401
Contact:Linna
Q Q:2300432737
E-mail:
sales-cpd@caerulumpharma.com
Web
:www.caerulumpharma.com
Products
No.
Product Name
CAS Number
Structure
CPDB1135
Olmutinib; Olita®
1353550-13-6
CPDB1136
Erlotinib Hydrochloride; Tarceva®
183319-69-9 (HCl), 183321-74-6 (free)
CPDB1137
Neratinib; HKI-272; PB-272; PF-0528767; WAY-179272
698387-09-6 (free base);
915942-22-2 (Neratinib Maleate)
CPDB1138
Dacomitinib; PF-00299804; PF-299; PF-299804; PF-804; PF-00299804-03; PF-00299804-3
1042385-75-0 (Dacomitinib Monohydrate), 1110813-31-4 (Dacomitinib free base)
CPDB1139
Veliparib; ABT-888; NSC-737664
912445-05-7 (Veliparib Hydrochloride);
912444-00-9 (Veliparib free base)
CPDB115
CO-1686
1374640-70-6
CPDB1213
BAY-1895344
1876467-74-1
CPDB137
AZD-9291 (Mesylate)
1421373-66-1
CPDB1536
PQR530
1927857-61-1
CPDB1540
MSC2530818
1883423-59-3
CPDB1541
MTX-211
1952236-05-3
CPDB1542
E-7046
1369489-71-3
CPDB1544
AZD-5153
1869912-39-9
CPDB1584
MDK-7526; Protein degrader 1
1448297-52-6 (Free base);
1448189-80-7 (HCl)
CPDB1587
THZ2
1604810-84-5
31
32
33
34
35
36
37
38
39
40
Copyright 2014 Shanghai Caerulum Pharma Discovery Co.,Ltd. All rights reserved. Supported by
www.hxchem.net